This page contains a Flash digital edition of a book.
RESEARCH INVESTMENTS (2005-2012)


$0 $1 $2 $3 $4 $5 $6 $7 $8


2005 2006 2007 2008 2009 2010 2011 2012


WHAT LIES AHEAD GRANTS-IN-AID OF RESEARCH 2012-2015


Dr. McKay


University of Calgary $358,336


Dr. Lomax Queen’s University $358,336


Dr. Gibson


University of British Columbia $358,336


Dr. Mallevaey University of Toronto $358,336


Drs. Surette, Moayyedi, Lee McMaster University $331,740


Dr. Jirik


University of Calgary $356,550


Drs. Amre, Mack, Deslandres, Janchou, Marcil University of Montreal/ CHU Ste-Justine


$299,350


Alternatively activated macrophages as a therapy for ulcerative colitis


Sympathetic neuroimmune


interactions during IBD


IBD risk through intestinal microbes and dietary fats


iNKT cells in IBD


Fecal biotherapy clinical trial in ulcerative colitis


Prion protein regulation of IBD in mice


Pre-clinical utility of epigenetic markers in Crohn’s disease in children


21 | RESEARCH REPORT 2012


Millions of Dollars


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24